1,000
Participants
Start Date
March 25, 2025
Primary Completion Date
July 31, 2027
Study Completion Date
July 31, 2028
Adaptive postoperative management based on minimal residual disease
participants will not receive postoperative treatment if (neoadjuvant therapy efficacy reaches pCR and) MRD results keep negative.
RECRUITING
Peking University People's Hospital, Beijing
Peking University
OTHER
Guangdong Provincial People's Hospital
OTHER
Jiangsu Cancer Institute & Hospital
OTHER
Shanghai Chest Hospital
OTHER
Shandong Cancer Hospital and Institute
OTHER
Shenzhen Third People's Hospital
OTHER
Second Xiangya Hospital of Central South University
OTHER
Shanghai Zhongshan Hospital
OTHER
Peking University First Hospital
OTHER
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
OTHER
National Institute for Occupational Safety and Health (NIOSH/CDC)
FED
Peking University People's Hospital
OTHER